- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids and their derivatives in struggle against melanoma
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-15
DOI
10.1007/s43440-021-00308-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
- (2020) Frank Friedrich Gellrich et al. Journal of Clinical Medicine
- Current Advances in the Treatment of BRAF-Mutant Melanoma
- (2020) Hima Patel et al. Cancers
- Oncolytic Viruses for the Treatment of Metastatic Melanoma
- (2020) Megan H. Trager et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Cannabinoids use in adolescents and young adults with cancer: a single-center survey
- (2020) Marta Podda et al. TUMORI
- Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
- (2020) Farjana Afrin et al. Cancers
- Cannabis and cannabinoids in cancer pain management
- (2020) Howard Meng et al. Current Opinion in Supportive and Palliative Care
- Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
- (2020) Andrea M. Tomko et al. Cancers
- Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
- (2020) Dhanush Haspula et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
- (2019) Tarek Taha et al. ONCOLOGIST
- Cannabinoid Ligands Targeting TRP Channels
- (2019) Chanté Muller et al. Frontiers in Molecular Neuroscience
- Cannabidiol Adverse Effects and Toxicity
- (2019) Marilyn A. Huestis et al. Current Neuropharmacology
- Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis
- (2019) Jing Wang et al. Biomed Research International
- Current state of melanoma diagnosis and treatment
- (2019) Lauren E. Davis et al. CANCER BIOLOGY & THERAPY
- UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
- (2019) Yochai Wolf et al. CELL
- Paternal activation of CB2 cannabinoid receptor impairs placental and embryonic growth via an epigenetic mechanism
- (2019) Elisa Innocenzi et al. Scientific Reports
- Surgical Management of Primary Cutaneous Melanoma
- (2019) Daniel Joyce et al. SURGICAL CLINICS OF NORTH AMERICA
- Epidemiology and Risk Factors of Melanoma
- (2019) Stephanie Carr et al. SURGICAL CLINICS OF NORTH AMERICA
- Anti-tumoural actions of cannabinoids
- (2018) Burkhard Hinz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Melanoma: What do all the mutations mean?
- (2018) Elizabeth J. Davis et al. CANCER
- N -acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities
- (2018) Pauline Bottemanne et al. DRUG DISCOVERY TODAY
- Long-Term Outcomes in Patients With BRAF V600–Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
- (2018) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity
- (2018) Francisco M Mouro et al. JOURNAL OF NEUROCHEMISTRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice
- (2018) Jimena Laura Frontera et al. NEUROPHARMACOLOGY
- Murine models of melanoma
- (2018) Jasmine Saleh PATHOLOGY RESEARCH AND PRACTICE
- Endocannabinoid System and Migraine Pain: An Update
- (2018) Rosaria Greco et al. Frontiers in Neuroscience
- Cannabinoid Delivery Systems for Pain and Inflammation Treatment
- (2018) Natascia Bruni et al. MOLECULES
- Medical Use of Cannabinoids
- (2018) Ana Isabel Fraguas-Sánchez et al. DRUGS
- Supraoptimal Cytokinin Content Inhibits Rice Seminal Root Growth by Reducing Root Meristem Size and Cell Length via Increased Ethylene Content
- (2018) Xiao Zou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model
- (2018) Erika Simmerman et al. JOURNAL OF SURGICAL RESEARCH
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic reviews
- (2017) Victor Schussel et al. PHYTOTHERAPY RESEARCH
- Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells
- (2017) Sara Carpi et al. TOXICOLOGY IN VITRO
- Cannabis, Cannabinoids, and Sleep: a Review of the Literature
- (2017) Kimberly A. Babson et al. Current Psychiatry Reports
- A novel peptide that improves metabolic parameters without adverse central nervous system effects
- (2017) Patrícia Reckziegel et al. Scientific Reports
- Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
- (2016) M. F. Sanmamed et al. ANNALS OF ONCOLOGY
- Metastatic melanoma treatment: Combining old and new therapies
- (2016) Ryan J. Davey et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
- (2016) Paula Morales et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Ligands for cannabinoid receptors, promising anticancer agents
- (2016) Marjan Nikan et al. LIFE SCIENCES
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Cannabinoid-induced autophagy: Protective or death role?
- (2016) Lia Costa et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells
- (2015) Sara Carpi et al. ANTI-CANCER DRUGS
- The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
- (2015) C Blázquez et al. CELL DEATH AND DIFFERENTIATION
- Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration
- (2015) Simona Pisanti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
- (2015) Jane L. Armstrong et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Differential role of cannabinoids in the pathogenesis of skin cancer
- (2015) Nicole Glodde et al. LIFE SCIENCES
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
- (2014) János Haskó et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anticancer activity of anandamide in human cutaneous melanoma cells
- (2013) Barbara Adinolfi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor 2 is upregulated in melanoma
- (2013) Hua Zhao et al. Journal of Cancer Research and Therapeutics
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
- (2012) Laurie Hamtiaux et al. BMC CANCER
- Revisiting CB1 Receptor as Drug Target in Human Melanoma
- (2012) István Kenessey et al. PATHOLOGY & ONCOLOGY RESEARCH
- The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft
- (2011) Mariagrazia Rita Scuderi et al. CANCER LETTERS
- A Randomized, Controlled Study to Investigate the Analgesic Efficacy of Single Doses of the Cannabinoid Receptor-2 Agonist GW842166, Ibuprofen or Placebo in Patients With Acute Pain Following Third Molar Tooth Extraction
- (2011) Thor Ostenfeld et al. CLINICAL JOURNAL OF PAIN
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
- (2010) L J Aronne et al. INTERNATIONAL JOURNAL OF OBESITY
- Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
- (2010) Yan Zhao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
- (2009) Sadiye Amcaoglu Rieder et al. IMMUNOBIOLOGY
- Signal transduction of the CB1 cannabinoid receptor
- (2009) Gábor Turu et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus
- (2009) J. E. Schlosburg et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More